48.60
-0.80
(-1.62%)
At close: April 16 at 8:04:40 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CNY | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 11 | 38 | 38 |
| Avg. Estimate | 13.83B | 14.61B | 61.34B | 69.9B |
| Low Estimate | 13.71B | 14.4B | 60.45B | 66.08B |
| High Estimate | 14.11B | 14.78B | 63.01B | 74.84B |
| Year Ago Sales | 11.9B | 12.77B | 53.29B | 61.34B |
| Sales Growth (year/est) | 16.16% | 14.42% | 15.10% | 13.95% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CLV.F | -- | -- | -- | -- |
| S&P 500 | 6.79% | 5.59% | 9.06% | 14.11% |
Upgrades & Downgrades
| Maintains | JP Morgan: Overweight to Overweight | 2/27/2025 |
| Reiterates | Benchmark: Buy to Buy | 2/25/2025 |
| Reiterates | Benchmark: Buy to Buy | 1/14/2025 |
| Maintains | Citigroup: Buy to Buy | 1/3/2025 |
| Maintains | Barclays: Overweight to Overweight | 11/20/2024 |
| Maintains | Macquarie: Outperform to Outperform | 11/20/2024 |